An Evaluation of Levamisole Alone or Levamisole plus 5-Fluorouracil as Surgical Adjuvant Treatment for Resectable Adenocarcinoma of the Colon

Association of Patient Demographic Characteristics and Insurance Status with Survival in Cancer Randomized Clinical Trials with Positive Findings

JM Unger;CD Blanke;M Leblanc;W Barlow;R Vaidya;M Fleury;SD Ramsey;DL Hershman JAMA Network Open Apr 1;3(4):e203842

PMid: PMID32352530 | PMC number: PMC7193331

The effect of positive SWOG treatment trials on survival of patients with cancer in the US population

JM Unger;M Leblanc;CD Blanke JAMA Oncology Oct 1;3(10):1345-1351

PMid: PMID28586789; PMC5710507

The impact of positive SWOG treatment trials on population survival

J Unger;M LeBlanc;C Blanke J Clin Oncol 35, 2017 (suppl; abstr 6513); American Society of Clinical Oncology Annual Meeting (June 2-6, 2017, Chicago, IL), poster discussion

Racial disparities in survival of patients with sex-specific cancers treated on Southwest Oncology Group clinical trials. PMC2724852; PMID: 19584328

KS Albain;JM Unger;JJ Crowley;CA Coltman;DL Hershman Journal of the National Cancer Institute 101(14):984-992

The Southwest Oncology Group: progress in cancer research [PMID18929152]

CA Coltman Seminars in Oncology 35(5):545-552

Differences in toxicity between men and women treated with 5-fluorouracil therapy for colorectal carcinoma

K Chansky;J Benedetti;JS Macdonald Cancer 103(6):1165-1171

A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients

DJ Sargent;RM Goldberg;SD Jacobson;JS Macdonald;R Labianca;DG Haller;LE Shepherd;JF Seitz;G Francini New England Journal of Medicine 345(15):1091-1097

Clinical correlation for colorectal cancers with microsatellite instability (MSI)

DP Chauhan;LC Lovato;A Goel;T Aoki;CR Boland;DJ Ahnen Gastroenterology 118(4)Suppl:A58(#499)

Surgery for recurrent colon cancer: Strategies for identifying resectable recurrence and success rates after resection.

RM Goldberg;TR Fleming;CM Tangen;CG Moertel;JS Macdonald;DG Haller;JA Laurie Annals of Internal Medicine 129(1):27-35

Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: A final report.

CG Moertel;TR Fleming;JS Macdonald;DG Haller;JA Laurie;CM Tangen;JS Ungerleider;WA Emerson;DC Tormey;JH Glick;MH Veeder;JA Mailliard Annals of Internal Medicine 122(5):321-326

The Intergroup Study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer.

CG Moertel;TR Fleming;JS Macdonald;DG Haller;JA Laurie;CM Tangen;JS Ungerleider;WA Emerson;DC Tormey;JH Glick;MH Veeder;JA Mailliard Journal of Clinical Oncology 13(12):2936-2943

Recognition and salvage of the patient with recurrent colon cancer.

C Moertel;T Fleming;J Macdonald;D Haller;J Laurie;C Tangen ASCO 12:224(#688)

Testing against ordered alternatives for censored survival data.

PY Liu;S Green;M Wolf;J Crowley JASA 88(421):153-160

An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer

CG Moertel;TR Fleming;JS Macdonald;DG Haller;JA Laurie;C Tangen JAMA 270(8):943-947

Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy

CG Moertel;TR Fleming;JS Macdonald;DG Haller;JA Laurie Journal of Clinical Oncology 11(12):2386-2390

The Intergroup study of fluorouracil (5-FU) plus levamisole (LEV) and levamisole alone as adjuvant therapy for stage C colon cancer. A final report.

C Moertel;T Fleming;J Macdonald;D Haller;J Laurie ASCO 11:161(#457)

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.

CG Moertel;TR Fleming;JS Macdonald;DG Haller;JA Laurie;PJ Goodman;JS Ungerleider;WA Emerson;DC Tormey;JH Glick;MH Veeder;JA Mailliard NEJM 322:352-358